Gene Mack insider trades

Open-market stock purchases and sales by Gene Mack, CEO, President at Gain Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2018.

Recent trades

DateStockTradeValue
Mar 24, 2026GANX Gain Therapeutics, IncBought (not open market)—

Companies traded

  • GANX Gain Therapeutics, Inc: 1 buy, last Mar 24, 2026
  • SLS SELLAS Life Sciences Group, Inc: other filings, last Apr 20, 2018

Get free alerts when Gene Mack files a new trade →